Company Filing History:
Years Active: 2022
Title: Innovations of Xiulian Du in Cancer Diagnostics and Therapeutics
Introduction
Xiulian Du is a prominent inventor based in Baltimore, MD (US), known for her significant contributions to cancer research. She has developed innovative solutions aimed at improving diagnostic and therapeutic methods for various types of cancer. Her work focuses on specific antigens and antibodies that play a crucial role in cancer detection and treatment.
Latest Patents
Xiulian Du holds a patent for her invention titled "Colon and pancreas cancer specific antigens and antibodies." This invention relates to the NPC-1 antigen on the MUC5AC protein, the 16C3 antigen on CEACAM5 and CEACAM6 proteins, and the 31.1 epitope on the A33 protein. These components are differentially expressed in cancers, including lung cancer, ovarian cancer, pancreas cancer, breast cancer, and colon cancer. The patent outlines diagnostic and therapeutic usages of these antigens, as well as the specific antibodies and methods associated with them.
Career Highlights
Du is currently employed at Precision Biologics, Inc., where she continues to advance her research in cancer diagnostics and therapeutics. Her work has garnered attention for its potential to improve patient outcomes through targeted therapies.
Collaborations
Throughout her career, Xiulian Du has collaborated with notable colleagues, including Janos Luka and Lewis Joe Stafford. These partnerships have contributed to the development and refinement of her innovative approaches in cancer research.
Conclusion
Xiulian Du's contributions to the field of cancer diagnostics and therapeutics highlight her role as a leading inventor in this critical area of medical research. Her innovative work continues to pave the way for advancements in cancer treatment and detection.